Viewing Study NCT00114192


Ignite Creation Date: 2025-12-24 @ 3:33 PM
Ignite Modification Date: 2026-03-18 @ 12:41 AM
Study NCT ID: NCT00114192
Status: COMPLETED
Last Update Posted: 2010-02-01
First Post: 2005-06-13
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Docetaxel and Thalidomide as Second-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Sponsor:
Organization: